Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05903469

Implicit and Explicit Assessment of Suicide Risk

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
108 (estimated)
Sponsor
Centre Hospitalier Universitaire, Amiens · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

In 2007 Nock \& Banaji developed a so-called implicit suicide risk measurement using a computer tool: the Implicit Association Test (IAT). This measurement, associated with traditional evaluations, makes it possible to better predict suicidal recurrence. In 2020, the Poitiers team of Tello was able to replicate these results on a French population. However, although a high IAT score predicts the onset of suicide at 1 year, there is no data on how this score changes over time nor even data concerning the measure's ability to differentiate a population with explicit suicidal ideation from a population without explicit suicidal ideation. The investigators therefore seek to demonstrate an evolution of implicit suicidal ideation over time by replicating the measurement at inclusion, at 6 months and at 12 months, for different patient profiles: Suicidal ideation vs No suicidal ideation and suicide attempt vs no suicide attempt. Patients will be recruited from the emergency-unit of CHU Amiens-Picardie and will take the suicide-IAT as well as various questionnaires.

Conditions

Interventions

TypeNameDescription
OTHERImplicit Attitude TestThe IAT (Implicit Attitude Test) is a method of indirectly measuring the relative strength of associations between different concepts stored in memory based on reaction times on computer. The general idea behind this measure is that an individual will be much faster to categorize an object into a predetermined category, if this categorization is consistent with their own way of processing information.

Timeline

Start date
2022-06-28
Primary completion
2025-12-01
Completion
2026-01-01
First posted
2023-06-15
Last updated
2025-05-29

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05903469. Inclusion in this directory is not an endorsement.